Azora Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

Azora Therapeutics General Information

Description

Developer of a therapeutic medicine intended to treat serious, debilitating inflammatory diseases. The company specializes in developing novel small-molecule new chemical entities for the treatment of autoimmune and inflammatory diseases like hidradenitis suppurativa and ulcerative colitis, enabling patients to get improved treatment against such diseases.

Contact Information

Formerly Known As
Meya Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4267 Valley Meadow Road
  • Encino, CA 91436
  • United States
+1 (818)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4267 Valley Meadow Road
  • Encino, CA 91436
  • United States
+1 (818)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azora Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Jun-2026 Completed Clinical Trials - Phase 1
2. Later Stage VC 08-Aug-2023 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 11-Jun-2021 $7.73M $7.73M Completed Pre-Clinical Trials
To view Azora Therapeutics’s complete valuation and funding history, request access »

Azora Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Azora Therapeutics’s complete cap table history, request access »

Azora Therapeutics Patents

Azora Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4493930-A1 Companion diagnostics and strategies for treatment with an aryl hydrocarbon receptor agonist compound Inactive 17-Mar-2022
US-20250195469-A1 Companion diagnostics and strategies for treatment with an aryl hydrocarbon receptor agonist compound Pending 17-Mar-2022
WO-2023178288-A1 Companion diagnostics and strategies for treatment with an aryl hydrocarbon receptor agonist compound Inactive 17-Mar-2022
AU-2022360542-A1 Derivatives of aryl hydrocarbon receptor agonists Pending 08-Oct-2021
CA-3233526-A1 Derivatives of aryl hydrocarbon receptor agonists Pending 08-Oct-2021 C07D209/36
To view Azora Therapeutics’s complete patent history, request access »

Azora Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azora Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
7G Bioventures Venture Capital Minority
Floating Point (Boston) Venture Capital Minority
Tarnagulla Ventures Venture Capital Minority
To view Azora Therapeutics’s complete investors history, request access »

Azora Therapeutics FAQs

  • When was Azora Therapeutics founded?

    Azora Therapeutics was founded in 2017.

  • Where is Azora Therapeutics headquartered?

    Azora Therapeutics is headquartered in Encino, CA.

  • What is the size of Azora Therapeutics?

    Azora Therapeutics has 2 total employees.

  • What industry is Azora Therapeutics in?

    Azora Therapeutics’s primary industry is Drug Discovery.

  • Is Azora Therapeutics a private or public company?

    Azora Therapeutics is a Private company.

  • What is Azora Therapeutics’s current revenue?

    The current revenue for Azora Therapeutics is .

  • How much funding has Azora Therapeutics raised over time?

    Azora Therapeutics has raised $8.32M.

  • Who are Azora Therapeutics’s investors?

    7G Bioventures, Floating Point (Boston), and Tarnagulla Ventures have invested in Azora Therapeutics.

  • When was Azora Therapeutics acquired?

    Azora Therapeutics was acquired on 11-Jun-2026.

  • Who acquired Azora Therapeutics?

    Azora Therapeutics was acquired by Adial Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process